David Shanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Latest Publications
- 1 December 2010
- Published by Oxford University Press (OUP) in International Health
- Vol. 2 (4) , 231-238
New guidelines and the development of an international consensus on recommendations for the antibiotic prophylaxis of infective endocarditis
During the last five years there has been a considerable change in attitude towards antibiotic prophylaxis of endocarditis in many countries so that far fewer cardiac patients are advised to receive prophylaxis in comparison with previous years. Much greater emphasis is now given to the maintenance of good oral hygiene as the main method of preventing endocarditis and prophylaxis is only recommended for patients with the highest risk cardiac conditions undergoing dental procedures. Most countries have now abandoned prophylaxis for urological and gastrointestinal procedures. The UK National Institute for Health and Clinical Excellence guidance, which does not recommend prophylaxis for any group of patients undergoing dental procedures, is regarded as too extreme by many experts in other countries. The assertion that more patients would die from fatal anaphylaxis after oral amoxicillin, the main prophylactic agent, than would die from endocarditis because prophylaxis is withheld, may not be correct since the risks of dying after oral amoxicillin have probably been overestimated. There is a lack of clinical evidence either for or against the efficacy of antibiotic prophylaxis. Unless convincing data is obtained from future research any new international consensus guidelines will continue to be based mainly on expert opinion rather than on good evidence.
- 1 December 2010
- Published by Oxford University Press (OUP) in International Health
- Vol. 2 (4) , 231-238
New guidelines and the development of an international consensus on recommendations for the antibiotic prophylaxis of infective endocarditis
During the last five years there has been a considerable change in attitude towards antibiotic prophylaxis of endocarditis in many countries so that far fewer cardiac patients are advised to receive prophylaxis in comparison with previous years. Much greater emphasis is now given to the maintenance of good oral hygiene as the main method of preventing endocarditis and prophylaxis is only recommended for patients with the highest risk cardiac conditions undergoing dental procedures. Most countries have now abandoned prophylaxis for urological and gastrointestinal procedures. The UK National Institute for Health and Clinical Excellence guidance, which does not recommend prophylaxis for any group of patients undergoing dental procedures, is regarded as too extreme by many experts in other countries. The assertion that more patients would die from fatal anaphylaxis after oral amoxicillin, the main prophylactic agent, than would die from endocarditis because prophylaxis is withheld, may not be correct since the risks of dying after oral amoxicillin have probably been overestimated. There is a lack of clinical evidence either for or against the efficacy of antibiotic prophylaxis. Unless convincing data is obtained from future research any new international consensus guidelines will continue to be based mainly on expert opinion rather than on good evidence.
- 1 April 2008
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 21 (2) , 191-199
New British and American guidelines for the antibiotic prophylaxis of infective endocarditis: do the changes make sense? A critical review
The British Society for Antimicrobial Chemotherapy and the American Heart Association have radically revised their guidelines for the antibiotic prophylaxis of endocarditis. This review discusses the evidence behind the most controversial changes and considers possible future developments. The new guidelines emphasize good oral hygiene for preventing viridans streptococcal endocarditis. Antibiotic prophylaxis for dental procedures is only recommended for patients with the highest-risk cardiac conditions. American Heart Association guidelines no longer recommend prophylaxis for urological and gastrointestinal procedures. While only up to 6% of endocarditis cases may be prevented by antibiotic prophylaxis there is controversy as to what to recommend for the individual cardiac patient undergoing a given procedure. The new guidelines about dental prophylaxis are based on epidemiological studies that failed to include sufficient subjects undergoing specific interventions. When considering viridans streptococcal rather than total bacteraemia rates, asserting that the prevalence of bacteraemia after invasive dental procedures is similar to that after toothbrushing may be incorrect. The British Society for Antimicrobial Chemotherapy report probably overestimates the risk of fatal anaphylaxis after an oral dose of amoxicillin. In contrast, the American Heart Association guidelines comment on the absence of any reports of fatal anaphylaxis associated with the antibiotic prophylaxis of endocarditis.
- 1 April 2008
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 21 (2) , 191-199
New British and American guidelines for the antibiotic prophylaxis of infective endocarditis: do the changes make sense? A critical review
The British Society for Antimicrobial Chemotherapy and the American Heart Association have radically revised their guidelines for the antibiotic prophylaxis of endocarditis. This review discusses the evidence behind the most controversial changes and considers possible future developments. The new guidelines emphasize good oral hygiene for preventing viridans streptococcal endocarditis. Antibiotic prophylaxis for dental procedures is only recommended for patients with the highest-risk cardiac conditions. American Heart Association guidelines no longer recommend prophylaxis for urological and gastrointestinal procedures. While only up to 6% of endocarditis cases may be prevented by antibiotic prophylaxis there is controversy as to what to recommend for the individual cardiac patient undergoing a given procedure. The new guidelines about dental prophylaxis are based on epidemiological studies that failed to include sufficient subjects undergoing specific interventions. When considering viridans streptococcal rather than total bacteraemia rates, asserting that the prevalence of bacteraemia after invasive dental procedures is similar to that after toothbrushing may be incorrect. The British Society for Antimicrobial Chemotherapy report probably overestimates the risk of fatal anaphylaxis after an oral dose of amoxicillin. In contrast, the American Heart Association guidelines comment on the absence of any reports of fatal anaphylaxis associated with the antibiotic prophylaxis of endocarditis.
- Open Access
- 12 July 2006
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 58 (4) , 895
Comment on: Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
Sir, Appendix 1 of the latest BSAC Working Party Report on Guide- lines for the Prevention of Endocarditis1 may be incorrect in implying that there is no risk from any dental procedure to patients with moderate-risk heart lesions and that prophylaxis should be stopped. To state categorically that there is no need for prophylaxis for these patients may be a step too far with the limited evidence currently available. It is well recognized that only a small number of cases of endocarditis may be related to previous dental manipulations.2 Nonetheless there is still insuf- ficient evidence to judge efficacy or lack of efficacy of antibiotic prophylaxis for individuals with susceptible heart lesions under- going high-risk dental procedures. The main results of the analysis of epidemiological evidence, referred to in the report and editorial,3 are from a single case-control study of adults in the USA4 and a study in the Netherlands.5 The USA study found no link between the total dental procedures and endocarditis but the authors could not comment on the role of specific high-risk dental procedures as only small numbers of these procedures were included. The study noted that 6 of 273 cases of endocarditis and 0 of 273 controls had a recent dental extraction, 11 of 273 cases and 7 of 273 controls had periodontal treatment and only 1 case, and no con- trols, had recent mouth or gingival surgery. Another case-control report in the Netherlands5 also had a limited study power due to the small numbers of individuals included. The authors of this study observed differences between cases and controls that suggested a causal relationship between endocarditis and procedures with a high risk of bacteraemia such as dental root work or extractions. They estimated that up to 6% of native valve disease endocarditis cases might be prevented by antibiotic prophylaxis of certain dental procedures. If this estimate were to be extrapolated to the UK there would be a limited impact on the total number of endocarditis cases but perhaps up to 100 individuals could have streptococcal endocard- itis prevented each year. Viridans streptococcal endocarditis can result in damaged valves that need subsequent cardiac surgery. A German case-control study of patients with prosthetic valves, undergoing procedures with or without antibiotic prophy- laxis, observed endocarditis developing within 2 weeks of the procedure, but only in cases not receiving prophylaxis, including two cases after tooth extraction.6 Imperiale7 observed a 91% protective efficacy for antibiotic prophylaxis of at risk dental procedures in another USA case-control study. Much larger case-control studies are required to ascertain actual risks associated with suspected high-risk dental procedures. These should include significant numbers of individuals having dental extractions, scaling and surgery in the mouth or gums. The BSAC 2006 report extensively references cases of bac- teraemia, and occasionally endocarditis, following non-dental procedures but fails to reference the numerous cases of endo- carditis following dental extraction.2 Spontaneous streptococcal bacteraemia is difficult to detect, with only 0-3% of pre- extraction blood cultures positive for viridans streptococci,8 whereas dental extraction is associated with 40-100% strepto- coccal bacteraemia rates.2 The Working Party report recommends antibiotic prophylaxis for dental extraction and other dental procedures for patients with high-risk cardiac conditions. Until there is more convincing evi- dence to change practice it is also logical to continue cover for patients with moderate-risk heart lesions undergoing high-risk dental procedures. Such moderate-risk heart lesions should include congenital or acquired heart valve lesions and non-cya- notic congenital heart disease. Single-dose amoxicillin prophylaxis is inexpensive, rarely associated with serious adverse reactions and unlikely to con- tribute significantly to global antibiotic resistance problems. It should still be recommended for high-risk dental procedures for patients with moderate-risk heart lesions.
- 12 July 2006
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 58 (4) , 895
Open AccessComment on: Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
Sir, Appendix 1 of the latest BSAC Working Party Report on Guide- lines for the Prevention of Endocarditis1 may be incorrect in implying that there is no risk from any dental procedure to patients with moderate-risk heart lesions and that prophylaxis should be stopped. To state categorically that there is no need for prophylaxis for these patients may be a step too far with the limited evidence currently available. It is well recognized that only a small number of cases of endocarditis may be related to previous dental manipulations.2 Nonetheless there is still insuf- ficient evidence to judge efficacy or lack of efficacy of antibiotic prophylaxis for individuals with susceptible heart lesions under- going high-risk dental procedures. The main results of the analysis of epidemiological evidence, referred to in the report and editorial,3 are from a single case-control study of adults in the USA4 and a study in the Netherlands.5 The USA study found no link between the total dental procedures and endocarditis but the authors could not comment on the role of specific high-risk dental procedures as only small numbers of these procedures were included. The study noted that 6 of 273 cases of endocarditis and 0 of 273 controls had a recent dental extraction, 11 of 273 cases and 7 of 273 controls had periodontal treatment and only 1 case, and no con- trols, had recent mouth or gingival surgery. Another case-control report in the Netherlands5 also had a limited study power due to the small numbers of individuals included. The authors of this study observed differences between cases and controls that suggested a causal relationship between endocarditis and procedures with a high risk of bacteraemia such as dental root work or extractions. They estimated that up to 6% of native valve disease endocarditis cases might be prevented by antibiotic prophylaxis of certain dental procedures. If this estimate were to be extrapolated to the UK there would be a limited impact on the total number of endocarditis cases but perhaps up to 100 individuals could have streptococcal endocard- itis prevented each year. Viridans streptococcal endocarditis can result in damaged valves that need subsequent cardiac surgery. A German case-control study of patients with prosthetic valves, undergoing procedures with or without antibiotic prophy- laxis, observed endocarditis developing within 2 weeks of the procedure, but only in cases not receiving prophylaxis, including two cases after tooth extraction.6 Imperiale7 observed a 91% protective efficacy for antibiotic prophylaxis of at risk dental procedures in another USA case-control study. Much larger case-control studies are required to ascertain actual risks associated with suspected high-risk dental procedures. These should include significant numbers of individuals having dental extractions, scaling and surgery in the mouth or gums. The BSAC 2006 report extensively references cases of bac- teraemia, and occasionally endocarditis, following non-dental procedures but fails to reference the numerous cases of endo- carditis following dental extraction.2 Spontaneous streptococcal bacteraemia is difficult to detect, with only 0-3% of pre- extraction blood cultures positive for viridans streptococci,8 whereas dental extraction is associated with 40-100% strepto- coccal bacteraemia rates.2 The Working Party report recommends antibiotic prophylaxis for dental extraction and other dental procedures for patients with high-risk cardiac conditions. Until there is more convincing evi- dence to change practice it is also logical to continue cover for patients with moderate-risk heart lesions undergoing high-risk dental procedures. Such moderate-risk heart lesions should include congenital or acquired heart valve lesions and non-cya- notic congenital heart disease. Single-dose amoxicillin prophylaxis is inexpensive, rarely associated with serious adverse reactions and unlikely to con- tribute significantly to global antibiotic resistance problems. It should still be recommended for high-risk dental procedures for patients with moderate-risk heart lesions.